Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)Michael Pfreundschuh, Markus Loeffler, Eva Lengfelder et al.|The Lancet Oncology|2008Cited by 1.1k
Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trialAndreas Jahn, G. Huebner, Hartmut Link et al.|British Journal of Cancer|2008Cited by 87
Community-driven development of a modified progression-free survival ratio for precision oncologyAndreas Möck, Anna Lena Illert, Christoph E. Heilig et al.|ESMO Open|2019Cited by 44